文献速递主动脉疾病

主动脉夹层患者主动脉分支的长期结局

Long-term fate of aortic branches in patients with aortic dissection.
PubMed 文献 · J Vasc Surg · 2021-02-14

基于Olmsted县人群队列,纳入58例有随访影像的主动脉夹层患者,评估分支相关事件及直径变化。急性期后15年无分支相关事件生存率为48%,分支扩张年均增长1.3±3.0 mm。B型夹层、假腔通畅及就诊时灌注不良综合征是晚期分支事件的预测因素。

要点

  • 主动脉夹层分支受累导致显著远期并发症,但无分支相关死亡。
  • B型夹层、假腔通畅及就诊时灌注不良综合征增加晚期分支事件风险。
  • 约三分之一患者随访中出现分支扩张,假腔通畅或马凡综合征者更明显。

核心结论

  • 主动脉夹层分支受累导致显著长期并发症,但无分支相关死亡。
  • B型夹层、假腔通畅及就诊时灌注不良综合征增加晚期分支事件风险。
  • 随访中约三分之一病例出现分支扩张,尤其假腔通畅或马凡综合征者。

研究设计与样本

  • 基于罗切斯特流行病学项目记录链接系统,识别1995至2015年Olmsted县新诊断主动脉夹层居民。
  • 纳入58例有>30天随访影像的患者,其中A型28例(48%),B型30例(52%)。
  • 主要结局为免于任何分支相关事件(急性期后>14天的干预、动脉瘤、灌注不良、破裂或死亡)。
  • 次要结局为主动脉分支直径变化,采用Cox比例风险模型和线性回归分析。

主要发现

  • 急性期后15年免于任何分支相关事件率为48%(95%CI 32%-70%)。
  • 15年内19例患者发生31起分支相关事件:干预12例(免于干预率76%,95%CI 63%-92%)、动脉瘤10例(67%,95%CI 50%-90%)、灌注不良8例(76%,95%CI 61%-94%)、破裂1例(94%,95%CI 84%-100%)。
  • 无分支相关死亡发生。
  • 主动脉分支总体增长率为1.3±3.0 mm/年;假腔通畅、初始分支直径及马凡综合征与直径增加显著相关。

临床怎么用

  • 对主动脉夹层患者,尤其B型、假腔通畅或就诊时灌注不良者,应长期监测分支相关事件。
  • 随访中注意分支直径变化,马凡综合征或假腔通畅者扩张风险更高。

局限性

  • 样本量较小(58例),来自单一县人群队列,外推需谨慎。
  • 仅纳入有>30天随访影像的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Late morbidity and mortality related to aortic branches in patients with aortic dissection (AD) have not been well described. We investigated the fate of aortic branches in a population cohort of patients with newly diagnosed AD. METHODS: We used the Rochester Epidemiology Project record linkage system to identify all Olmsted County, Minnesota, residents with a diagnosis of AD from 1995 to 2015. Only patients with >30 days of available follow-up imaging studies were included in the present analysis. The primary outcome was freedom from any branch-related event (any intervention, aneurysm, malperfusion, rupture, or death occurring after the acute phase >14 days). The secondary outcome was the diameter change in the aortic branches. Univariate and multivariable Cox proportional hazards models were used to identify the predictors of branch-related events. Univariate and multivariate linear regression models were used to assess the aortic branch growth rate. RESULTS: Of 77 total incident AD cases, 58 patients who had survived and had imaging follow-up studies available were included, 28 (48%) with type A and 30 (52%) with type B AD. The presentation was acute in 39 patients (67%), 6 (10%) of whom had had branch malperfusion. Of 177 aortic branches involved by the AD, 81 (46%) had arisen from the true lumen, 33 (19%) from the false lumen, and 63 (36%) from both. After the acute phase, freedom from any branch-related event at 15 years was 48% (95% confidence interval [CI], 32%-70%). A total of 31 branch-related events had occurred in 19 patients within 15 years, including 12 interventions (76% freedom; 95% CI, 63%-92%), 10 aneurysms (67% freedom; 95% CI, 50%-90%), 8 cases of malperfusion (76% freedom; 95% CI, 61%-94%), and 1 rupture (94% freedom; 95% CI, 84%-100%). No branch-related deaths had occurred. Type B AD (hazard ratio [HR], 3.5; 95% CI, 1.1-10.8; P = .033), patency of the aortic false lumen (HR, 6.8; 95% CI, 1.1-42.2; P = .038), and malperfusion syndrome at presentation (HR, 6.0; 95% CI, 1.3-28.6; P = .023) were predictors of late aortic branch-related events. The overall growth rate of aortic branches was 1.3 ± 3.0 mm annually. Patency of the aortic false lumen, initial branch diameter, and Marfan syndrome were significantly associated with diameter increase. CONCLUSIONS: In patients with AD, aortic branch involvement was responsible for significant long-term morbidity, without any related mortality. Type B AD, patency of the aortic false lumen, and malperfusion syndrome at presentation resulted in a greater risk of branch events during the long-term follow-up. Dilatation of the aortic branches was observed in one third of cases during follow-up, especially in the case of a patent aortic false lumen or the presence of Marfan syndrome.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Squizzato F, Oderich GS, Bower TC, et al. Long-term fate of aortic branches in patients with aortic dissection. J Vasc Surg. 2021. PMID: 33592297. doi:10.1016/j.jvs.2021.01.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。